AU2003222664A1 - Production of functional antibodies in filamentous fungi - Google Patents
Production of functional antibodies in filamentous fungiInfo
- Publication number
- AU2003222664A1 AU2003222664A1 AU2003222664A AU2003222664A AU2003222664A1 AU 2003222664 A1 AU2003222664 A1 AU 2003222664A1 AU 2003222664 A AU2003222664 A AU 2003222664A AU 2003222664 A AU2003222664 A AU 2003222664A AU 2003222664 A1 AU2003222664 A1 AU 2003222664A1
- Authority
- AU
- Australia
- Prior art keywords
- production
- filamentous fungi
- functional antibodies
- antibodies
- functional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37388902P | 2002-04-18 | 2002-04-18 | |
| US60/373,889 | 2002-04-18 | ||
| US41153702P | 2002-09-18 | 2002-09-18 | |
| US41154002P | 2002-09-18 | 2002-09-18 | |
| US60/411,540 | 2002-09-18 | ||
| US60/411,537 | 2002-09-18 | ||
| US45213403P | 2003-03-04 | 2003-03-04 | |
| US60/452,134 | 2003-03-04 | ||
| PCT/US2003/012246 WO2003089614A2 (en) | 2002-04-18 | 2003-04-17 | Production of functional antibodies in filamentous fungi |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003222664A8 AU2003222664A8 (en) | 2003-11-03 |
| AU2003222664A1 true AU2003222664A1 (en) | 2003-11-03 |
Family
ID=29255585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003222664A Abandoned AU2003222664A1 (en) | 2002-04-18 | 2003-04-17 | Production of functional antibodies in filamentous fungi |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20040018573A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1495055B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006512891A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003222664A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1495055T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003089614A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040018573A1 (en) * | 2002-04-18 | 2004-01-29 | Power Scott D | Production of functional antibodies in filamentous fungi |
| US7208585B2 (en) * | 2002-09-18 | 2007-04-24 | Genencor International, Inc. | Protein purification |
| DK1578774T3 (da) * | 2002-09-18 | 2014-02-03 | Danisco Us Inc | Oprensning af immunoglobuliner |
| JP2007501011A (ja) * | 2003-08-01 | 2007-01-25 | ジェネンテック・インコーポレーテッド | 制限多様性配列を有する結合型ポリペプチド |
| ES2285543T3 (es) * | 2003-11-05 | 2007-11-16 | Ares Trading S.A. | Procedimiento para la purificacion de la proteina de union a il-18. |
| JP2007535913A (ja) * | 2004-01-21 | 2007-12-13 | ノボザイムス アクティーゼルスカブ | ヘテロカリオン菌類又は菌類宿主細胞におけるモノクローナル抗体の生成 |
| DK1941025T3 (da) * | 2005-10-17 | 2011-09-26 | Novozymes As | Brug af svampemutanter til ekspression af antistoffer |
| EP4793360A2 (en) | 2006-03-31 | 2026-08-19 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
| US20080026376A1 (en) | 2006-07-11 | 2008-01-31 | Huaming Wang | KEX2 cleavage regions of recombinant fusion proteins |
| US8198046B2 (en) | 2006-07-11 | 2012-06-12 | Danisco Us Inc. | KEX2 cleavage regions of recombinant fusion proteins |
| WO2008057637A2 (en) * | 2006-07-21 | 2008-05-15 | Novozymes, Inc. | Methods of increasing secretion of polypeptides having biological activity |
| US20100062491A1 (en) * | 2007-01-05 | 2010-03-11 | Novozymes A/S | Overexpression of the Chaperone BIP in a Heterokaryon |
| EP2129685B1 (en) * | 2007-03-21 | 2013-11-20 | Danisco US Inc. | Over expression of foldases and chaperones improves protein production |
| JP5769142B2 (ja) * | 2007-09-04 | 2015-08-26 | 独立行政法人酒類総合研究所 | ピヒア属酵母において異種タンパク質を高分泌させる方法 |
| ES2687808T3 (es) | 2007-09-26 | 2018-10-29 | Chugai Seiyaku Kabushiki Kaisha | Región constante de anticuerpo modificado |
| EP3127921A1 (en) | 2007-09-26 | 2017-02-08 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substition in cdr |
| JP2011507507A (ja) * | 2007-12-21 | 2011-03-10 | フジフィルム・マニュファクチュアリング・ヨーロッパ・ベスローテン・フエンノートシャップ | マルチマー性前駆体のinvivoタンパク質分解的プロセシングによる関心対象のタンパク質の分泌収量の改善 |
| EP2282769A4 (en) | 2008-04-29 | 2012-04-25 | Abbott Lab | DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND ITS USES |
| KR20110016959A (ko) | 2008-06-03 | 2011-02-18 | 아보트 러보러터리즈 | 이원 가변 도메인 면역글로불린 및 이의 용도 |
| EP2297209A4 (en) | 2008-06-03 | 2012-08-01 | Abbott Lab | IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF |
| US8822645B2 (en) | 2008-07-08 | 2014-09-02 | Abbvie Inc. | Prostaglandin E2 dual variable domain immunoglobulins and uses thereof |
| JP2010183885A (ja) * | 2009-02-13 | 2010-08-26 | Kobe Univ | タンパク質の製造方法およびそれに用いる発現ベクター |
| TWI544077B (zh) | 2009-03-19 | 2016-08-01 | 中外製藥股份有限公司 | Antibody constant region change body |
| CN102549012B (zh) | 2009-05-07 | 2015-07-01 | 诺维信生物制药丹麦公司 | 纯化白蛋白的方法 |
| US20120059155A1 (en) * | 2009-05-07 | 2012-03-08 | Novozymes Biopharma Dk A/S | Method of Controlling O-Linked Glycosylation of Antibodies |
| WO2010141468A1 (en) * | 2009-06-01 | 2010-12-09 | Way Jeffrey C | Methods and molecules for yield improvement involving metabolic engineering |
| MX2012002651A (es) | 2009-09-01 | 2012-05-22 | Abbott Lab | Inmunoglobulinas de dominio variable doble y usos de las mismas. |
| AR078651A1 (es) | 2009-10-15 | 2011-11-23 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| UY32979A (es) | 2009-10-28 | 2011-02-28 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| KR20130100118A (ko) | 2010-08-03 | 2013-09-09 | 아비에 인코포레이티드 | 이원 가변 도메인 면역글로불린 및 이의 용도 |
| US9046513B2 (en) | 2010-08-26 | 2015-06-02 | Abbvie Inc. | Dual variable domain immunoglobulins and uses thereof |
| EP3252076B1 (en) | 2011-01-14 | 2019-09-04 | The Regents Of The University Of California | Diagnostic use of antibodies against ror-1 protein |
| AR089529A1 (es) | 2011-12-30 | 2014-08-27 | Abbvie Inc | Proteinas de union especificas duales dirigidas contra il-13 y/o il-17 |
| BR112014016587A2 (pt) | 2012-01-05 | 2020-10-27 | Novartis Ag | células fúngicas filamentosas deficientes de protease e métodos de uso das mesmas |
| KR101505157B1 (ko) * | 2012-05-08 | 2015-03-24 | 주식회사 종근당 | 항―ErbB2 항체 변이체 |
| DK2852610T3 (en) | 2012-05-23 | 2018-09-03 | Glykos Finland Oy | PRODUCTION OF FUCOSYLED GLYCOPROTEIN |
| PE20151179A1 (es) | 2012-11-01 | 2015-09-12 | Abbvie Inc | Inmunoglobulinas de dominio variable dual anti-vegf/dll4 y usos de las mismas |
| WO2014152145A1 (en) * | 2013-03-15 | 2014-09-25 | Bristol-Myers Squibb Company | Methods for producing antibodies |
| AU2014227732A1 (en) | 2013-03-15 | 2015-09-17 | Abbvie Inc. | Dual specific binding proteins directed against IL-1 beta and IL-17 |
| WO2015004241A2 (en) | 2013-07-10 | 2015-01-15 | Novartis Ag | Multiple proteases deficient filamentous fungal cells and methods of use thereof |
| AU2015293949B2 (en) | 2014-07-21 | 2019-07-25 | Teknologian Tutkimuskeskus Vtt Oy | Production of glycoproteins with mammalian-like N-glycans in filamentous fungi |
| US10093733B2 (en) | 2014-12-11 | 2018-10-09 | Abbvie Inc. | LRP-8 binding dual variable domain immunoglobulin proteins |
| KR101515535B1 (ko) | 2015-01-28 | 2015-05-06 | 주식회사 종근당 | 항―ErbB2 항체 변이체 |
| JP7082484B2 (ja) | 2015-04-01 | 2022-06-08 | 中外製薬株式会社 | ポリペプチド異種多量体の製造方法 |
| TW201710286A (zh) | 2015-06-15 | 2017-03-16 | 艾伯維有限公司 | 抗vegf、pdgf及/或其受體之結合蛋白 |
| SG11201803989WA (en) | 2015-12-28 | 2018-06-28 | Chugai Pharmaceutical Co Ltd | Method for promoting efficiency of purification of fc region-containing polypeptide |
| SG10201607778XA (en) | 2016-09-16 | 2018-04-27 | Chugai Pharmaceutical Co Ltd | Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use |
| CN107674900B (zh) * | 2017-06-12 | 2021-05-14 | 诺利如一(安阳)生物科技有限公司 | 一种采用串联膜浓缩大豆肽的工艺方法 |
| JP7234932B2 (ja) | 2017-10-10 | 2023-03-08 | 味の素株式会社 | タンパク質の製造法 |
| TWI827585B (zh) | 2018-03-15 | 2024-01-01 | 日商中外製藥股份有限公司 | 對茲卡病毒具有交叉反應性的抗登革病毒抗體及其使用方法 |
| WO2020198731A2 (en) | 2019-03-28 | 2020-10-01 | Danisco Us Inc | Engineered antibodies |
| US20230203191A1 (en) | 2020-03-30 | 2023-06-29 | Danisco Us Inc | Engineered antibodies |
| CN115836127B (zh) | 2020-06-11 | 2026-03-13 | 味之素株式会社 | 蛋白的制造方法 |
| WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
| WO2024015953A1 (en) | 2022-07-15 | 2024-01-18 | Danisco Us Inc. | Methods for producing monoclonal antibodies |
| EP4574840A1 (en) | 2022-08-15 | 2025-06-25 | The University of Tokyo | Method for producing immunoglobulin or multimer immunoglobulin using filamentous fungus |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3009104C2 (de) | 1980-03-10 | 1990-10-04 | Odenwald-Chemie GmbH, 6901 Schönau | Verwendung eines Epoxydharzes zur Herstellung von feuerhemmenden Schichten oder Überzügen und Verfahren zur Herstellung derselben |
| CA1338400C (en) | 1983-08-31 | 1996-06-18 | David H. Gelfand | Recombinant fungal cellulases |
| US20020061560A1 (en) * | 1985-08-29 | 2002-05-23 | Genencor, Inc. | DNA sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
| NZ217373A (en) | 1985-08-29 | 1990-10-26 | Genencor Inc | Production of heterologous peptide in filamentous fungi, vectors and dna |
| US5679543A (en) * | 1985-08-29 | 1997-10-21 | Genencor International, Inc. | DNA sequences, vectors and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
| US5364770A (en) * | 1985-08-29 | 1994-11-15 | Genencor International Inc. | Heterologous polypeptides expressed in aspergillus |
| US5618920A (en) * | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US5013649A (en) * | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
| US5610034A (en) * | 1987-04-29 | 1997-03-11 | Alko Group Ltd. | Immunoglobulin production by trichoderma |
| US5218093A (en) | 1989-03-01 | 1993-06-08 | Allelix Biopharmaceuticals, Inc. | EGF variants and pharmaceutical use thereof |
| GB9215540D0 (en) * | 1992-07-22 | 1992-09-02 | Celltech Ltd | Protein expression system |
| WO1994025591A1 (en) * | 1993-04-29 | 1994-11-10 | Unilever N.V. | PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE) |
| US5643745A (en) * | 1994-02-03 | 1997-07-01 | University Of Hawaii | Heterologous dimeric proteins produced in heterokaryons |
| US5683899A (en) * | 1994-02-03 | 1997-11-04 | University Of Hawaii | Methods and compositions for combinatorial-based discovery of new multimeric molecules |
| US6300114B1 (en) * | 1994-07-29 | 2001-10-09 | Rohm Enzyme Finland Oy | Sequences of xylanase and xylanase expression vectors |
| AU1750697A (en) * | 1996-01-19 | 1997-08-11 | Novo Nordisk Biotech, Inc. | Morphological mutants of filamentous fungi |
| US6140113A (en) * | 1996-03-28 | 2000-10-31 | The Johns Hopkins University | Polynucleotides encoding molecular complexes which modify immune responses |
| US6265204B1 (en) | 1997-01-17 | 2001-07-24 | Genencor International, Inc. | DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi |
| GB9703406D0 (en) * | 1997-02-19 | 1997-04-09 | Chiron Spa | Expression of heterologous proteins |
| US5994511A (en) * | 1997-07-02 | 1999-11-30 | Genentech, Inc. | Anti-IgE antibodies and methods of improving polypeptides |
| US6232112B1 (en) * | 1997-11-24 | 2001-05-15 | Flinders Technologies Pty Ltd Of Flinders University | Reagents and methods for diversification of DNA |
| ZA9811162B (en) * | 1997-12-12 | 2000-06-07 | Genentech Inc | Treatment with anti-ERBB2 antibodies. |
| BR9908226A (pt) * | 1998-02-25 | 2000-10-24 | Lexigen Pharm Corp | Melhoramento da meia vida de circulação de proteìnas de fusão com base em anticorpo |
| AU1219000A (en) | 1998-10-22 | 2000-05-08 | Regents Of The University Of California, The | Functionally assembled antigen-specific intact recombinant antibody and a methodfor production thereof |
| US6767701B1 (en) * | 1998-10-26 | 2004-07-27 | Novozymes A/S | Methods of constructing and screening a DNA library of interest in filamentous fungal cells |
| EP1077600A4 (en) * | 1998-10-30 | 2003-04-09 | Univ Jefferson | PRODUCTION OF BIOMEDICAL PEPTIDES AND PROTEINS IN PLANTS USING VEGETABLE VECTORS |
| US7094571B2 (en) * | 2000-10-27 | 2006-08-22 | The Board Of Regents Of The University Of Texas System | Combinatorial protein library screening by periplasmic expression |
| US7083945B1 (en) * | 2000-10-27 | 2006-08-01 | The Board Of Regents Of The University Of Texas System | Isolation of binding proteins with high affinity to ligands |
| DK1407017T3 (en) * | 2000-11-07 | 2009-09-21 | Zymogenetics Inc | Human receptor for tumor nekrose faktor |
| CN1306272C (zh) * | 2000-11-17 | 2007-03-21 | 罗切斯特大学 | 筛选编码抗原特异性免疫球蛋白分子或其抗原特异性片段的方法 |
| PL403488A1 (pl) * | 2001-05-24 | 2013-07-08 | Zymogenetics, Inc. | Zastosowanie bialka fuzyjnego TACI-immunoglobulina, bialko fuzyjne, czasteczka kwasu nukleinowego kodujaca bialko fuzyjne, kompozycja farmaceutyczna i sposób wytwarzania bialka fuzyjnego TACI-immunoglobulina |
| US20040018573A1 (en) * | 2002-04-18 | 2004-01-29 | Power Scott D | Production of functional antibodies in filamentous fungi |
| US7611866B2 (en) * | 2002-07-15 | 2009-11-03 | Board Of Regents, The University Of Texas System | Selection of bacterial inner-membrane anchor polypeptides |
| HUE035898T2 (en) * | 2002-12-16 | 2018-05-28 | Genentech Inc | Immunoglobulin variants and their applications |
| AU2004204462B2 (en) * | 2003-01-09 | 2012-03-08 | Macrogenics, Inc. | Dual expression vector system for antibody expression in bacterial and mammalian cells |
| US20060024782A1 (en) * | 2004-01-21 | 2006-02-02 | Novozymes A/S | Production of a monoclonal antibody in a heterokaryon filamentous fungus or in a filamentous fungal host cell |
| US20060029947A1 (en) * | 2004-03-18 | 2006-02-09 | Board Of Regents, The University Of Texas System | Combinatorial protein library screening by periplasmic expression |
| DK2102239T3 (da) * | 2006-11-30 | 2012-05-29 | Res Dev Foundation | Forbedrede immunoglobulin-biblioteker |
| US8629245B2 (en) * | 2007-05-01 | 2014-01-14 | Research Development Foundation | Immunoglobulin Fc libraries |
-
2003
- 2003-04-17 US US10/418,836 patent/US20040018573A1/en not_active Abandoned
- 2003-04-17 EP EP03719861.1A patent/EP1495055B1/en not_active Revoked
- 2003-04-17 JP JP2003586327A patent/JP2006512891A/ja active Pending
- 2003-04-17 DK DK03719861.1T patent/DK1495055T3/da active
- 2003-04-17 WO PCT/US2003/012246 patent/WO2003089614A2/en not_active Ceased
- 2003-04-17 AU AU2003222664A patent/AU2003222664A1/en not_active Abandoned
-
2004
- 2004-12-09 US US11/007,886 patent/US7977067B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US7977067B2 (en) | 2011-07-12 |
| EP1495055A2 (en) | 2005-01-12 |
| AU2003222664A8 (en) | 2003-11-03 |
| US20040018573A1 (en) | 2004-01-29 |
| EP1495055A4 (en) | 2007-08-01 |
| WO2003089614A3 (en) | 2004-02-26 |
| JP2006512891A (ja) | 2006-04-20 |
| WO2003089614A2 (en) | 2003-10-30 |
| EP1495055B1 (en) | 2013-08-14 |
| DK1495055T3 (da) | 2013-11-11 |
| US20050158825A1 (en) | 2005-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003222664A8 (en) | Production of functional antibodies in filamentous fungi | |
| AU2003903909A0 (en) | Production methods | |
| AU2003252240A1 (en) | Piezoelectric component and production method therefor | |
| AU2003279819A1 (en) | Shrimp and the production thereof | |
| AU2003228501A1 (en) | Gemstone cut | |
| EP1666592A4 (en) | FUNGAL IMMUNOMODULATORY PROTEIN PRODUCED BY MICROORGANISM AND USES THEREOF | |
| AU2003301358A1 (en) | Database accelerator | |
| AU2003210433A1 (en) | Method for the production of metallised plastic moulded pieces and use thereof | |
| AU2003268795A1 (en) | Pallets and methods for manufacture and use thereof | |
| AU2003289557A1 (en) | Adhesive brassiere and its manufacturing method | |
| AU2003214836A1 (en) | Combined gemstone | |
| AU2002328643A1 (en) | Deep wooden container and production method therefor | |
| AU2003261856A1 (en) | Lead frame and method of manufacturing the lead frame | |
| EP1633816B8 (en) | Wood product and method therefor | |
| EP1421871A3 (en) | Fragrant ornament | |
| AU2003223470A1 (en) | Gemstone | |
| AU2003286128A1 (en) | Expression of polypeptides in filamentous fungi | |
| AU2003276202A1 (en) | Laminated materials and method for the production thereof | |
| AU2003276433A1 (en) | Selective expression in filamentous fungi | |
| AU2003231408A1 (en) | Annular ornament | |
| AU2003237590A1 (en) | Decorative door and manufacture thereof | |
| AU2003236172A1 (en) | Use of ganoderma in the production of tobacco | |
| AUPS306402A0 (en) | Assay method | |
| AU2003256159A1 (en) | A method of analysing relative epitope appearance in a plurality of samples | |
| AU2003205985A1 (en) | Identification of changes in broadcast database |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |